Clinical Trial Update: Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ruxolitinib phosphate in patients with atypical chronic myeloid leukemia (BCR-ABL1 negative) and chronic neutrophilic leukemia has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Chronic Myeloid Leukemia
• Neutrophilic Leukemia

Drugs mentioned

• Ruxolitinib phosphate (ruxolitinib phosphate)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Neutrophilic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2020-11-16